Related Experiment Video

Updated: Apr 20, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.9K

Human embryonic stem cells vs human induced pluripotent stem cells for cardiac repair

Lili Barad1, Revital Schick1, Naama Zeevi-Levin2

  • 1Department of Physiology, Technion, Haifa, Israel; The Rappaport Family Institute, Technion, Haifa, Israel; Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.

The Canadian Journal of Cardiology
|December 3, 2014
PubMed

Insights

Human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) show promise for cardiac regeneration after myocardial infarction. This review examines their potential and challenges in cell replacement therapy for heart failure.

Area of Science:

  • Regenerative Medicine
  • Cardiology
  • Stem Cell Biology

Background:

  • The heart has limited regenerative capacity, making myocardial infarction (MI) a leading cause of heart failure.
  • Current treatments like heart transplantation are limited by donor organ availability.
  • Cell replacement therapy using cardiomyocytes offers a potential alternative.

Purpose of the Study:

  • To critically review research on human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) for cardiac regeneration in MI models.
  • To discuss current controversies, challenges, and future directions in this field.

Main Methods:

  • Comprehensive literature review of studies using hESC-derived cardiomyocytes (hESC-CMs) and hiPSC-derived cardiomyocytes (hiPSC-CMs) in MI models.
  • Analysis of proposed mechanisms of action for these cells in the myocardium.

Main Results:

  • hESCs and hiPSCs can differentiate into cardiomyocytes, offering potential for cardiac repair.
  • Research has explored various candidate cells and their therapeutic mechanisms in the myocardium.
  • Significant progress has been made, but challenges remain in clinical translation.

Conclusions:

  • hESC-CMs and hiPSC-CMs hold significant promise for cardiac regenerative medicine.
  • Further research is needed to address unresolved issues and challenges for effective cell replacement therapy.
  • Future directions include optimizing cell differentiation, delivery, and integration for myocardial regeneration.

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

8.3K
Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction10:46

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction

Published on: November 3, 2011

20.9K

Related Concept Videos

Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.7K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.4K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

4.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
33.6K